← Leaderboards
Rachel Lynn Tomko
University Of Missouri-Columbia
$1,721,987
Attributed
$3,378,990
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,874,532 · 6
By mechanism
R01$3,163,319 · 3
U54$1,495,542 · 1
R03$150,687 · 1
F31$64,984 · 1
Top collaborators
- Aimee L Mcrae-Clark6 shared
- Bethany Jacobs Wolf2 shared
- Amber Jarnecke1 shared
- Erin A Mcclure1 shared
Most similar at University Of Missouri-Columbia
Same institution · by research overlap
- Zachary Massey$526,921
- Allie Michelle Spiekerman$41,649
- Charles H Nilon$4,790,663
- Tommy S Parker$70,733
Others in their field
Top investigators on “Participant”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$407,724,307
- Lawrence Corey · Fred Hutchinson Cancer Center$333,313,234
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Albert Lazzarini · California Institute Of Technology$300,431,866
Research focus
ParticipantSamplingTreatment OutcomePatient Self-ReportAbstinenceAlcohol Use DisorderLiteratureFuturePharmaceutical PreparationsAdultBehavioralBehaviorPersonsMobile ApplicationPatternPharmacotherapyDiariesMarijuana UsePhysiologicalEvaluationCannabisDrug UsageMarijuana Use DisorderClinical Research
Grant awards (12)
MUSC Specialized Center of Research Excellence on Sex Differences Renewal 2022$1,495,542
U54 · FY2025 · DA
Prospective changes in patient-reported and objective functioning following reduction of cannabis use$686,692
R01 · FY2025 · DA · contact PI
Real-world Assessment of Social Functioning during OUD Treatment: Integrating Reports from Patients and their Concerned Significant Others$680,046
R01 · FY2025 · DA
Gender and Sex Hormone Influences on Cannabis Use Disorder Remission$397,185
R01 · FY2024 · DA · contact PI
Gender and Sex Hormone Influences on Cannabis Use Disorder Remission$426,430
R01 · FY2023 · DA · contact PI
Gender and Sex Hormone Influences on Cannabis Use Disorder Remission$105,670
R01 · FY2023 · DA · contact PI
A novel data-driven approach for personalizing smoking cessation pharmacotherapy$75,250
R03 · FY2023 · CA · contact PI
Gender and Sex Hormone Influences on Cannabis Use Disorder Remission$431,010
R01 · FY2022 · DA · contact PI
A novel data-driven approach for personalizing smoking cessation pharmacotherapy$75,437
R03 · FY2022 · CA · contact PI
Gender and Sex Hormone Influences on Cannabis Use Disorder Remission$436,286
R01 · FY2021 · DA · contact PI
Mood, Physiological Arousal, and Alcohol Use$31,023
F31 · FY2013 · AA · contact PI
Mood, Physiological Arousal, and Alcohol Use$33,961
F31 · FY2012 · AA · contact PI